Share This Page
Drug Price Trends for NDC 00904-5780
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-5780
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| HEARTBURN RELIEF 20 MG TABLET | 00904-5780-51 | 0.14686 | EACH | 2025-12-17 |
| HEARTBURN RELIEF 20 MG TABLET | 00904-5780-17 | 0.14686 | EACH | 2025-12-17 |
| HEARTBURN RELIEF 20 MG TABLET | 00904-5780-51 | 0.14799 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-5780
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00904-5780
Introduction
NDC 00904-5780 pertains to a specific pharmaceutical product registered within the National Drug Code (NDC) system. Comprehensive market analysis and price projection for this drug require delineating its therapeutic category, market demand, competitive landscape, regulatory environment, and pricing dynamics. This report synthesizes current market conditions, upcoming trends, and key factors influencing the drug's value trajectory, aiding stakeholders in strategic decision-making.
Product Profiling and Therapeutic Context
NDC 00904-5780 corresponds to [Insert specific drug name, formulation, dosage, and indication]. Its clinical use primarily targets [indicate condition, e.g., rheumatoid arthritis, cancer, infectious diseases], positioning it within a competitive landscape that includes [list similar marketed drugs and biosimilars if applicable].
The drug’s therapeutic efficacy, safety profile, and dosing regimen influence its adoption rate. In particular, innovations such as targeted therapies or biologics with improved safety profiles could impact the commercial viability of NDC 00904-5780.
Current Market Landscape
Market Demand and Patient Population
The global demand for [drug's therapeutic area] is driven by an aging population, increasing prevalence of [related diseases], and advances in diagnostic capabilities. For example, [statistics from recent epidemiological studies, e.g., CDC reports] indicate a rising incidence of [condition], underpinning long-term growth prospects.
Market segmentation, based on geography, age, and healthcare setting, delineates key demand nodes. North America currently dominates due to high healthcare expenditure and regulatory approvals, with Europe and Asia-Pacific rapidly expanding market share owing to increasing treatment adoption and unmet needs.
Competitive Landscape
The competitive environment includes direct rivals and emerging biosimilars or generics. Major players such as [list of companies] have developed alternatives that influence pricing strategies and market share. Patent expirations or exclusivity periods also shape market access, offering potential for generic or biosimilar entrants.
Regulatory and Reimbursement Factors
Regulatory approval, particularly from the FDA and EMA, is critical. Recent guidance documents and expedited approval pathways, such as Fast Track or Breakthrough Therapy designations, could accelerate market entry. Reimbursement policies, influenced by cost-effectiveness analyses and formulary decisions, directly impact revenue potential.
Price Evolution: Historical and Projected
Historical Pricing Trends
Historically, pricing for [drug class] has experienced fluctuations driven by patent protections, market exclusivity, and manufacturing costs. For instance, biologic drugs within similar categories saw initial high prices translating into steady declines post-patent expiry.
Current Price Benchmarks
As of Q1 2023, the average wholesale acquisition cost (WAC) for comparable drugs ranges from \$X to \$Y per dose or treatment course, depending on formulation and indication. Biosimilars entering the market have exerted downward pressure, with price reductions averaging Z% upon launch.
Price Projection Factors
Future pricing trajectories depend on the following determinants:
- Regulatory Status: Approval milestones and patent protections.
- Market Penetration: Adoption rates influenced by clinical guidelines and physician prescribing behavior.
- Competitive Dynamics: Entry of biosimilars or generics typically halves or reduces prices by 40-70%.
- Manufacturing and Supply Chain Costs: Innovations reducing costs could enable more aggressive pricing strategies.
- Reimbursement Landscape: Payer negotiations and formulary placements influence net pricing.
5-Year Price Outlook
Based on current trends, the price of NDC 00904-5780 is projected to evolve as follows:
| Year | Estimated Wholesale Price (WAC) | Key Drivers |
|---|---|---|
| 2023 | \$X per treatment course | Competitive positioning; patent status |
| 2024 | \$X - 10% | Anticipated launch of biosimilars; formulary negotiations |
| 2025 | \$X - 20% | Increased biosimilar market share; increased payer pressure |
| 2026 | \$X - 30% | Further biosimilar uptake; possible patent litigations |
| 2027 | \$X - 40% | Consolidation of biosimilar market; improved manufacturing efficiencies |
(Note: The actual numerical figures should be filled based on current market data and trend analyses.)
Strategic Considerations
- Pricing Strategies: Incorporating value-based pricing models aligned with clinical outcomes can justify premium prices and foster payer acceptance.
- Market Access: Early engagement with payers and formulary committees is essential to secure favorable positioning.
- Lifecycle Management: Patent strategies, including supplementary protection certificates (SPCs), can extend exclusivity and pricing power.
- Pipeline Development: Investment in combination therapies or biomarkers could expand indications and sustain demand.
Risks and Challenges
- Regulatory Delays: Johnson & Johnson's (or other manufacturers') pending approvals could shift market dynamics.
- Price Erosion: Biosimilar entries threaten price stability, necessitating proactive market positioning.
- Reimbursement Cuts: Healthcare cost containment policies may reduce optimal pricing margins.
- Manufacturing Disruptions: Supply chain vulnerabilities could impact availability and pricing.
Conclusion
The market for NDC 00904-5780 is poised for moderate growth, conditioned by patent protections, competitive biosimilar entries, and evolving healthcare policies. Price projections suggest a declining trend aligned with biosimilar penetration, yet opportunities for premium pricing remain for products with differentiated clinical profiles. Strategic positioning, including early market access initiatives and lifecycle management, will be critical in optimizing value over the forecast horizon.
Key Takeaways
- The global demand for drugs in [therapeutic area] is expanding, driven by epidemiological trends, offering favorable growth prospects.
- Pricing is expected to decline over the next five years due to biosimilar competition, yet a strong clinical profile can sustain higher price points.
- Market access strategies and stakeholder engagement are essential for maximizing revenue and operational stability.
- Patent management and lifecycle extension tactics will influence long-term pricing and profit margins.
- Continuous monitoring of regulatory developments and competitive moves is vital to adapt strategies proactively.
FAQs
-
What is the primary therapeutic use of NDC 00904-5780?
It is primarily used for [specific indication], targeting patients suffering from [condition]. -
How does biosimilar competition impact pricing for this drug?
Biosimilar entry typically causes significant price reductions, potentially between 40-70%, depending on market acceptance and reimbursement policies. -
What are the main factors influencing market demand for this drug?
Increasing disease prevalence, expanded indications, worldwide aging populations, and improved diagnostic methods drive demand. -
When is the expected patent expiry or exclusivity period for NDC 00904-5780?
Exact dates depend on intellectual property status; ongoing patent protections or litigation may influence timing. -
How can manufacturers extend the product lifecycle beyond patent expiry?
Strategies include developing combination therapies, obtaining new indications, optimizing manufacturing processes, or pursuing new formulations.
References
- [Pharmaceutical Market Intelligence Reports, 2022-2023]
- [FDA Regulatory and Approval Data]
- [Industry Reports on Biosimilar Market Trends]
- [Global Disease Prevalence Studies, CDC, WHO]
- [Healthcare Policy and Reimbursement Analysis, 2023]
More… ↓
